SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-21-147745
Filing Date
2021-05-03
Accepted
2021-05-03 15:15:29
Documents
3
Group Members
ACCESS INDUSTRIES HOLDINGS (BVI) L.P.ACCESS INDUSTRIES MANAGEMENT, LLCACCESS INDUSTRIES, LLCAI LIFE SCIENCES INVESTMENTS LLCAI LSI-SPV LLCLEN BLAVATNIK

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d149542dsc13d.htm SC 13D 180201
2 EX-99.1 d149542dex991.htm EX-99.1 11736
3 EX-99.2 d149542dex992.htm EX-99.2 7290
  Complete submission text file 0001193125-21-147745.txt   201094
Mailing Address C/O ACCESS INDUSTRIES MANAGEMENT, LLC. 730 FIFTH AVENUE, 20TH FLOOR NEW YORK NY 10019
Business Address C/O ACCESS INDUSTRIES MANAGEMENT, LLC. 730 FIFTH AVENUE, 20TH FLOOR NEW YORK NY 10019 212 247 6400
Access Industries Holdings LLC (Filed by) CIK: 0001391297 (see all company filings)

IRS No.: 721620814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Subject) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89449 | Film No.: 21883177
SIC: 2834 Pharmaceutical Preparations